D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 16 710 KRW 2.26%
Market Cap: 734.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dongkook Pharmaceutical Co Ltd
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Minority Interest
â‚©80B
CAGR 3-Years
48%
CAGR 5-Years
29%
CAGR 10-Years
79%
Yuhan Corp
KRX:000100
Minority Interest
â‚©56.5B
CAGR 3-Years
74%
CAGR 5-Years
36%
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Minority Interest
â‚©37.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Minority Interest
â‚©165.8B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
11%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Minority Interest
â‚©80.9B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
10%
C
Celltrion Pharm Inc
KOSDAQ:068760
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dongkook Pharmaceutical Co Ltd
Glance View

Market Cap
734.7B KRW
Industry
Pharmaceuticals

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Intrinsic Value
19 388.02 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Dongkook Pharmaceutical Co Ltd's Minority Interest?
Minority Interest
80B KRW

Based on the financial report for Sep 30, 2024, Dongkook Pharmaceutical Co Ltd's Minority Interest amounts to 80B KRW.

What is Dongkook Pharmaceutical Co Ltd's Minority Interest growth rate?
Minority Interest CAGR 10Y
79%

Over the last year, the Minority Interest growth was 167%. The average annual Minority Interest growth rates for Dongkook Pharmaceutical Co Ltd have been 48% over the past three years , 29% over the past five years , and 79% over the past ten years .

Back to Top